Nationally Recognized Ophthalmologist Ehsan Sadri, M.D. FACS and Industry Veteran Tom Mitro Appointed to Visiox’s Board of Directors

Tue June 7, 2022 | 09:10 am
Press Release, Uncategorized

Nationally Recognized Ophthalmologist Ehsan Sadri, M.D. FACS and Industry Veteran Tom Mitro Appointed to Visiox’s Board of Directors

Ehsan Sadri, M.D. FACS and Tom Mitro bring deep ophthalmology and industry innovation experience to further accelerate Visiox's product...

Timber Pharmaceuticals to Host Conference Call Discussing Positive Topline Results from Phase 2b CONTROL Study of Congenital Ichthyosis for Lead Asset, TMB-001

Wed November 17, 2021 | 08:00 am
Press Release

Timber Pharmaceuticals to Host Conference Call Discussing Positive Topline Results from Phase 2b CONTROL Study of Congenital Ichthyosis for Lead Asset, TMB-001

call to be held on Monday, November 22 nd at 10:00am ET BASKING RIDGE, NJ, Nov. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tim...

PaxMedica selected by American Academy of Child and Adolescent Psychiatry (AACAP) to Present Data from its Recent Phase 2 Trial of PAX-101 (IV suramin) in Children with Autism Spectrum Disorder (ASD) in the Research Pipeline Program

Thu August 19, 2021 | 06:16 pm
Press Release

PaxMedica selected by American Academy of Child and Adolescent Psychiatry (AACAP) to Present Data from its Recent Phase 2 Trial of PAX-101 (IV suramin) in Children with Autism Spectrum Disorder (ASD) in the Research Pipeline Program

• David Hough, MD, CMO of PaxMedica will present trial results at the upcoming AACAP Annual Meeting during the “Research Pipeline: New ...